The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors

Neuroendocrine tumors (NET) are often metastatic at the time of diagnosis. Metastatic well-differentiated (G1/G2) NET may display a wide range of behaviors, ranging from indolent to aggressive, even within apparently homogeneous categories. Thus, selecting the optimal treatment strategy is a challen...

Descripción completa

Detalles Bibliográficos
Autor principal: Hindié, Elif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399583/
https://www.ncbi.nlm.nih.gov/pubmed/28435455
http://dx.doi.org/10.7150/thno.19588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399583/
https://www.ncbi.nlm.nih.gov/pubmed/28435455
http://dx.doi.org/10.7150/thno.19588

Ejemplares similares